Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease

Rachel M. Golonka; Piu Saha; X. Beng San Yeoh; Saurabh Chattopadhyay; Andrew T. Gewirtz; Bina Joe; Matam Vijay-Kumar

doi:10.1152/PHYSIOLGENOMICS.00033.2020

Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease

Rachel M. Golonka, Piu Saha, X. Beng San Yeoh, Saurabh Chattopadhyay, Andrew T. Gewirtz, Bina Joe, Matam Vijay-Kumar

Microbiology, Immunology, and Molecular Genetics

Research output: Contribution to journal › Editorial

79 Scopus citations

Original language	English
Pages (from-to)	217-221
Number of pages	5
Journal	Physiological Genomics
Volume	52
Issue number	5
DOIs	https://doi.org/10.1152/PHYSIOLGENOMICS.00033.2020
State	Published - 2020

Funding

M. Vijay-Kumar is supported by National Institutes of Health (NIH) R01Grant CA-219144. B. Joe is supported by NIH R01 Grant HL-143082. S. Chattopadhyay is supported by NIH Grant AA-026017, the Medical Research Society, and the University of Toledo College of Medicine and Life Sciences. P. Saha is supported by the Crohn’s and Colitis Foundation Research Fellowship Award 522820.

Funders	Funder number
National Society of Medical Research
National Institutes of Health (NIH)	HL-143082, AA-026017
National Childhood Cancer Registry – National Cancer Institute	R01CA219144
Crohn's and Colitis Foundation of America	522820
University of Toledo College of Medicine and Life Sciences

ASJC Scopus subject areas

Physiology
Genetics

Access to Document

10.1152/PHYSIOLGENOMICS.00033.2020

Cite this

@article{449bd8573ef246faabf1786b36aa4450,

title = "Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease",

author = "Golonka, \{Rachel M.\} and Piu Saha and Yeoh, \{X. Beng San\} and Saurabh Chattopadhyay and Gewirtz, \{Andrew T.\} and Bina Joe and Matam Vijay-Kumar",

year = "2020",

doi = "10.1152/PHYSIOLGENOMICS.00033.2020",

language = "English",

volume = "52",

pages = "217--221",

number = "5",

}

TY - JOUR

T1 - Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease

AU - Golonka, Rachel M.

AU - Saha, Piu

AU - Yeoh, X. Beng San

AU - Chattopadhyay, Saurabh

AU - Gewirtz, Andrew T.

AU - Joe, Bina

AU - Vijay-Kumar, Matam

PY - 2020

Y1 - 2020

UR - https://www.scopus.com/pages/publications/85083865800

UR - https://www.scopus.com/inward/citedby.url?scp=85083865800&partnerID=8YFLogxK

U2 - 10.1152/PHYSIOLGENOMICS.00033.2020

DO - 10.1152/PHYSIOLGENOMICS.00033.2020

M3 - Editorial

C2 - 32275178

AN - SCOPUS:85083865800

SN - 1094-8341

VL - 52

SP - 217

EP - 221

JO - Physiological Genomics

JF - Physiological Genomics

IS - 5

ER -

Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this